Melanie Schorr Haines, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anorexia Nervosa | 15 | 2023 | 1363 | 2.880 |
Why?
|
Bone Density | 14 | 2023 | 3561 | 1.360 |
Why?
|
Overweight | 10 | 2024 | 2428 | 1.260 |
Why?
|
Body Composition | 11 | 2022 | 2455 | 1.210 |
Why?
|
Absorptiometry, Photon | 13 | 2023 | 1749 | 1.010 |
Why?
|
Myostatin | 1 | 2024 | 129 | 0.860 |
Why?
|
Insulin-Like Growth Factor I | 7 | 2023 | 1943 | 0.850 |
Why?
|
Paranoid Disorders | 1 | 2023 | 61 | 0.840 |
Why?
|
Sarcopenia | 2 | 2022 | 376 | 0.790 |
Why?
|
Hypokalemia | 1 | 2023 | 153 | 0.770 |
Why?
|
Obesity | 12 | 2024 | 13065 | 0.770 |
Why?
|
Insulin Resistance | 4 | 2024 | 3974 | 0.760 |
Why?
|
Leptin | 2 | 2023 | 1598 | 0.650 |
Why?
|
Acromegaly | 3 | 2022 | 316 | 0.540 |
Why?
|
Human Growth Hormone | 4 | 2022 | 648 | 0.530 |
Why?
|
Spine | 3 | 2017 | 1142 | 0.490 |
Why?
|
Bone Density Conservation Agents | 1 | 2022 | 797 | 0.490 |
Why?
|
Pregnanolone | 2 | 2019 | 67 | 0.440 |
Why?
|
Thinness | 2 | 2017 | 483 | 0.440 |
Why?
|
Amenorrhea | 3 | 2023 | 484 | 0.430 |
Why?
|
Fractures, Bone | 1 | 2023 | 2063 | 0.360 |
Why?
|
Hydrocortisone | 3 | 2022 | 1836 | 0.360 |
Why?
|
Adipose Tissue | 4 | 2020 | 3335 | 0.360 |
Why?
|
Cross-Sectional Studies | 18 | 2023 | 26351 | 0.350 |
Why?
|
Calcium | 1 | 2023 | 5793 | 0.350 |
Why?
|
Oxytocin | 2 | 2020 | 402 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12242 | 0.340 |
Why?
|
Muscle, Skeletal | 3 | 2022 | 4984 | 0.340 |
Why?
|
Estrogens | 2 | 2021 | 1531 | 0.320 |
Why?
|
Bone Diseases, Metabolic | 2 | 2019 | 411 | 0.320 |
Why?
|
Finite Element Analysis | 2 | 2019 | 441 | 0.310 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2019 | 190 | 0.300 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2018 | 68 | 0.300 |
Why?
|
Androstane-3,17-diol | 1 | 2017 | 20 | 0.300 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.290 |
Why?
|
Adrenal Insufficiency | 1 | 2019 | 194 | 0.290 |
Why?
|
Pelvic Bones | 2 | 2020 | 270 | 0.280 |
Why?
|
Bone and Bones | 3 | 2022 | 2589 | 0.270 |
Why?
|
Thyroid Nodule | 1 | 2013 | 766 | 0.270 |
Why?
|
Intra-Abdominal Fat | 3 | 2017 | 623 | 0.270 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 415 | 0.260 |
Why?
|
Hip | 1 | 2017 | 255 | 0.260 |
Why?
|
Young Adult | 18 | 2022 | 60045 | 0.260 |
Why?
|
Subcutaneous Fat | 2 | 2017 | 402 | 0.250 |
Why?
|
Pituitary-Adrenal System | 2 | 2016 | 557 | 0.250 |
Why?
|
Estradiol | 2 | 2023 | 1949 | 0.240 |
Why?
|
Affective Symptoms | 1 | 2017 | 418 | 0.240 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2016 | 705 | 0.230 |
Why?
|
Endocrine System Diseases | 1 | 2016 | 250 | 0.230 |
Why?
|
Nutrition Surveys | 2 | 2022 | 1734 | 0.220 |
Why?
|
Lumbar Vertebrae | 2 | 2023 | 1885 | 0.210 |
Why?
|
Female | 31 | 2024 | 396943 | 0.210 |
Why?
|
Adult | 27 | 2024 | 223542 | 0.200 |
Why?
|
Bone Remodeling | 2 | 2022 | 583 | 0.190 |
Why?
|
Body Weight | 3 | 2017 | 4630 | 0.190 |
Why?
|
Tibia | 1 | 2017 | 1075 | 0.190 |
Why?
|
Pituitary Apoplexy | 1 | 2021 | 29 | 0.190 |
Why?
|
Liver Cirrhosis | 2 | 2022 | 1950 | 0.180 |
Why?
|
Middle Aged | 21 | 2024 | 223418 | 0.180 |
Why?
|
Body Fat Distribution | 1 | 2022 | 245 | 0.180 |
Why?
|
Progesterone | 2 | 2019 | 750 | 0.180 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 241 | 0.170 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2020 | 20 | 0.170 |
Why?
|
Radius | 1 | 2023 | 443 | 0.170 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2016 | 1994 | 0.170 |
Why?
|
Follicular Phase | 1 | 2019 | 143 | 0.160 |
Why?
|
Luteal Phase | 1 | 2019 | 138 | 0.160 |
Why?
|
Humans | 37 | 2024 | 768451 | 0.160 |
Why?
|
Body Mass Index | 4 | 2022 | 13030 | 0.160 |
Why?
|
Spinal Fractures | 1 | 2015 | 712 | 0.160 |
Why?
|
Vasopressins | 1 | 2020 | 353 | 0.150 |
Why?
|
Hypopituitarism | 1 | 2020 | 251 | 0.150 |
Why?
|
Growth Hormone | 3 | 2023 | 573 | 0.150 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9507 | 0.150 |
Why?
|
Male | 19 | 2024 | 364781 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2018 | 2666 | 0.150 |
Why?
|
Testosterone | 2 | 2023 | 2493 | 0.140 |
Why?
|
Critical Illness | 1 | 2019 | 2754 | 0.130 |
Why?
|
Carrier Proteins | 1 | 2019 | 4948 | 0.130 |
Why?
|
Disease Management | 1 | 2016 | 2533 | 0.130 |
Why?
|
Cushing Syndrome | 1 | 2016 | 241 | 0.120 |
Why?
|
Anxiety | 2 | 2017 | 4655 | 0.120 |
Why?
|
Estrogen Replacement Therapy | 1 | 2021 | 1209 | 0.120 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2013 | 43 | 0.110 |
Why?
|
Weight-Bearing | 2 | 2017 | 533 | 0.110 |
Why?
|
Depressive Disorder | 1 | 2016 | 3738 | 0.110 |
Why?
|
Somatostatin | 2 | 2020 | 448 | 0.100 |
Why?
|
Pituitary Neoplasms | 1 | 2021 | 1325 | 0.100 |
Why?
|
Blood Glucose | 2 | 2022 | 6429 | 0.100 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6527 | 0.100 |
Why?
|
Menopause | 1 | 2019 | 1651 | 0.090 |
Why?
|
Prevalence | 3 | 2022 | 15880 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4355 | 0.090 |
Why?
|
Adolescent | 10 | 2021 | 89168 | 0.090 |
Why?
|
Adenoma | 1 | 2021 | 2163 | 0.090 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2019 | 30 | 0.090 |
Why?
|
Globulins | 1 | 2019 | 19 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2331 | 0.080 |
Why?
|
Models, Biological | 1 | 2015 | 9505 | 0.080 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 1131 | 0.080 |
Why?
|
Ergolines | 1 | 2017 | 57 | 0.070 |
Why?
|
Lipodystrophy | 1 | 2017 | 145 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4362 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 998 | 0.060 |
Why?
|
Peptides, Cyclic | 1 | 2017 | 393 | 0.060 |
Why?
|
Aged | 8 | 2024 | 171520 | 0.060 |
Why?
|
Adipokines | 1 | 2016 | 309 | 0.060 |
Why?
|
Risk Assessment | 1 | 2016 | 24311 | 0.060 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 756 | 0.060 |
Why?
|
Anthropometry | 1 | 2018 | 1343 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 708 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1197 | 0.050 |
Why?
|
Prednisone | 1 | 2017 | 1568 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14728 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 54914 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15638 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39430 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 30028 | 0.050 |
Why?
|
Premenopause | 1 | 2016 | 1039 | 0.050 |
Why?
|
Administration, Oral | 1 | 2019 | 4041 | 0.050 |
Why?
|
Exercise Test | 1 | 2018 | 2186 | 0.040 |
Why?
|
Receptors, Somatotropin | 1 | 2020 | 58 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20762 | 0.040 |
Why?
|
Liver | 2 | 2023 | 7575 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1898 | 0.040 |
Why?
|
Causality | 1 | 2016 | 1255 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2017 | 22293 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2021 | 716 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 13026 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2023 | 12450 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8635 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6035 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2019 | 533 | 0.030 |
Why?
|
Pituitary Diseases | 1 | 2016 | 136 | 0.030 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 141 | 0.030 |
Why?
|
Health Status | 1 | 2018 | 4096 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 1149 | 0.030 |
Why?
|
United States | 1 | 2022 | 73121 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 552 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 81834 | 0.030 |
Why?
|
Boston | 1 | 2016 | 9361 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1538 | 0.020 |
Why?
|
Weight Gain | 1 | 2022 | 2357 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3346 | 0.020 |
Why?
|
Comorbidity | 1 | 2016 | 10601 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6320 | 0.020 |
Why?
|
Risk Factors | 2 | 2018 | 74915 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13497 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15965 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1389 | 0.020 |
Why?
|
Depression | 1 | 2017 | 8235 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20231 | 0.020 |
Why?
|
Cohort Studies | 1 | 2019 | 41797 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14766 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65409 | 0.010 |
Why?
|